The Aveir VR Leadless Pacemaker (Abbott, Chicago, IL) recently was approved by the US
Food and Drug Administration, and joined the Micra (Medtronic, Minneapolis, MN)
transcatheter pacing system in the realm of nontransvenous cardiovascular implantable
devices. The Aveir VR offers design improvements over its predecessor, the Nanostim (St.
Jude Medical). There are recommendations for the perioperative management of
conventional transvenous pacemakers, but leadless pacemakers add a new layer of …